ASF1A activators encompass a group of chemical agents that modulate the activity of Anti-Silencing Function 1A (ASF1A), a histone chaperone that plays a critical role in DNA replication and repair, as well as the regulation of chromatin structure. ASF1A facilitates the deposition and removal of histones during nucleosome assembly and disassembly, which is essential for processes such as transcription, replication, and repair. Activation of ASF1A, therefore, can have profound impacts on chromatin dynamics and gene expression.
The mechanisms by which ASF1A activators function may be direct or indirect. Direct activators may interact with ASF1A, stabilizing the protein or promoting its interaction with histones, thereby enhancing its chaperone activity. This could involve binding to ASF1A at a site that induces a conformational change conducive to its chaperone function or that prevents its degradation, ensuring that it is available in greater quantities to participate in chromatin assembly/disassembly. Indirect activators might operate by influencing the signaling pathways that regulate ASF1A expression or post-translational modifications. These activators could elevate the expression levels of ASF1A by enhancing transcription or by stabilizing mRNA, resulting in increased protein synthesis. Alternatively, they might inhibit negative regulatory pathways, leading to a reduction in ASF1A degradation and an overall increase in its activity within the cell. In the context of research, ASF1A activators are valuable tools for probing the fundamental aspects of chromatin biology and the epigenetic mechanisms that govern gene expression. By modulating ASF1A activity, scientists can observe the changes in nucleosome assembly and disassembly and the subsequent effects on DNA accessibility and transcriptional output. This enables the investigation into how ASF1A contributes to the maintenance of genomic integrity and the fine-tuning of the epigenetic landscape during cell cycle progression.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea is a ribonucleotide reductase inhibitor that induces replication stress. This stress necessitates DNA repair mechanisms, leading to an increased demand for ASF1A's role in histone deposition. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
VE-821 is an ATR inhibitor. By inhibiting ATR, it contributes to replication stress, thus necessitating enhanced ASF1A function in related histone deposition and DNA repair mechanisms. | ||||||
SCH 900776 | 891494-63-6 | sc-364611 sc-364611A | 5 mg 10 mg | $255.00 $338.00 | ||
SCH 900776 is a CHK1 inhibitor. By inhibiting CHK1, it disrupts the ATR-CHK1 pathway and thus indirectly enhances ASF1A’s functional activity in histone deposition and DNA repair. | ||||||
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is a PARP inhibitor. It induces DNA damage, thus necessitating ASF1A's role in histone deposition during DNA repair. | ||||||
Rucaparib | 283173-50-2 | sc-507419 | 5 mg | $150.00 | ||
Rucaparib is another PARP inhibitor. It also induces DNA damage and activates ASF1A's role in histone deposition during repair. | ||||||
Aphidicolin | 38966-21-1 | sc-201535 sc-201535A sc-201535B | 1 mg 5 mg 25 mg | $84.00 $306.00 $1104.00 | 30 | |
Aphidicolin is a DNA polymerase alpha inhibitor, causing replication fork stalling. This enhances the demand for ASF1A's role in histone deposition during stalled replication forks. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin is a topoisomerase I inhibitor that causes DNA damage, thus increasing the demand for ASF1A's function in histone deposition during DNA repair. | ||||||
MRN-ATM Pathway Inhibitor, Mirin | 299953-00-7 | sc-203144 | 10 mg | $141.00 | 4 | |
Mirin is an MRE11 inhibitor that impairs DNA double-strand break repair. This disruption necessitates ASF1A's role in histone deposition during the repair process. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide is a topoisomerase II inhibitor that induces DNA damage, which requires ASF1A's role in histone deposition during DNA repair. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin intercalates into DNA, causing DNA damage and necessitating ASF1A's role in histone deposition during DNA repair. | ||||||